Truqap® (capivasertib)
for Breast Cancer

Truqap (capivasertib) is a targeted therapy used to treat HR-positive, HER2-negative breast cancer with abnormal PIK3CA, AKT1, or PTEN genes. As an AKT inhibitor, Truqap blocks pathways that help cancer cells grow and survive, slowing cancer progression.

Heart
Other top medicines used to treat Breast Cancer